Prosecution Insights
Last updated: November 04, 2026

Life Technologies AS

Technology area: Biotechnology & Pharmaceuticals

1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days

Analysis

Life Technologies AS is active in the Biotechnology & Pharmaceuticals technology area with a company patent portfolio that currently shows 1 pending office action. This single action indicates a very specific point of engagement with the patent office. The presence of 1 pending office action suggests that the company's current prosecution resources are dedicated to a single matter within this complex technical field.

The organizational structure of this prosecution is highly centralized, involving 1 distinct examiner and 1 distinct art unit. This means that the pending office action is not distributed across different units or individuals, but is instead focused in one place. Such a concentrated footprint allows for a direct and consistent dialogue with the patent office, as there are no competing examiner perspectives to manage within the current portfolio.

HOLLAND, PAUL J is identified as the busiest examiner, holding 1 busiest examiner pending action. Since the total number of pending office actions is 1, this examiner is handling the company's active prosecution. The alignment of 1 distinct examiner with 1 distinct art unit for this single action highlights a streamlined and focused approach to the company's current patent acquisitions.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

1
Total Pending OAs
0
Non-Final OAs
0
Final Rejections
1
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

1
Overdue
0
Due this week
0
Due this month
0
Due in next 60 days
0
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
1
Medium (100%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only1 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

1
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

10 h
Manual time on pending OAs
2 h
Time saved (low, 20%)
4 h
Time saved (mid, 35%)
0.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
HOLLAND, PAUL J 1 57.5% +64.5%

Interview Candidates (1)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18252283 COMPOSITIONS AND METHODS FOR NUCLEIC ACID ISOLATION HOLLAND, PAUL J 2d overdue

Top Art Units

Art UnitApps
1656 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18252283 COMPOSITIONS AND METHODS FOR NUCLEIC ACID ISOLATION HOLLAND, PAUL J 1656 §103 Non-Final OA 2d overdue Pending May 09, 2023

Managing Life Technologies AS's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does Life Technologies AS have?

Life Technologies AS has 1 pending office actions as of November 2026, spread across 1 art units and 1 examiners.

Which USPTO examiner handles the most Life Technologies AS applications?

Paul J Holland has the most, with 1 of Life Technologies AS's pending office actions.

What technology area are Life Technologies AS's patent applications in?

Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month